JPRN-UMIN000029597已完成未知
Revascularization by Peripheral Blood Mononuclear Cell Transplantation - Revascularization by Peripheral Blood Mononuclear Cell Transplantation
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have severe hypersensitivity or history of side effects to aphaeresis. 2) Patients who have malignant tumor or history of malignancy within the past 3 years. 3) Patients who have experienced acute myocardial infarction, unstable angina pectoris, myocarditis or cerebral infarction within 3 months. 4) Patients with active infection. 5) Patients who are pregnant or might be pregnant. 6) Patients with proliferative diabetic retinopathy (untreated, medium-term and late proliferative retinopathy) the end of treatment example is excluded. 7) Patients with platelets less than 70,000 platelets in blood test just before apheresies. 8) Patients with less than serum albumin 2 mg/dL. 9) Patients who are judged inappropriate for this trial by their attending physician.
研究者
相似试验
已完成
Unknown
Evaluation of two dental materials in regenerative treatment of non-vital teeth with incomplete root developmentTreatment of necrotic immature teeth with apical periodontitisOral HealthISRCTN69846868Damascus University20
招募中
Unknown
Establishment of Peripheral Blood-Derived Induced Pluripotent Stem Cells (iPS Cells) in Patients with Gastric PolyposisJPRN-UMIN000052317Okayama University80
未知
不适用
Peripheral blood mononuclear cell implantation for patients with severe ischemic heart diseaseSevere ischemic heart diseaseJPRN-UMIN000001289Department of Cardiovascular Science and Medicine,Graduate School of Medicine,Chiba University30
已完成
3 期
Occlusive/Stenotic Peripheral artery REvascularization studyJPRN-UMIN000003291Terumo Corporation100
已完成
3 期
Occlusive/Stenotic Peripheral artery REvascularization studY for LONG stentPeripheral arterial disease of lower extremities by a stenotic or occlusive de novo lesion at SFA/PAJPRN-UMIN000006636Terumo Corporation35